
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
Joseph Pantginis Maintained (ATNM) at Strong Buy and Held Target at $50 on, Mar 19th, 2024


🞛 This publication is a summary or evaluation of another publication
Joseph Pantginis of HC Wainwright & Co., Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy and Held Target at $50 on, Mar 19th, 2024.
Joseph has made no other calls on ATNM in the last 4 months.
There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Yuan Zhi of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $16 on, Monday, December 11th, 2023